Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,460
| Closed | -$223K | – | 80 |
|
|
2021
Q4 | $223K | Hold |
1,460
| – | – | 0.05% | 82 |
|
|
2021
Q3 | $236K | Hold |
1,460
| – | – | 0.05% | 79 |
|
|
2021
Q2 | $239K | Hold |
1,460
| – | – | 0.05% | 73 |
|
|
2021
Q1 | $220K | Hold |
1,460
| – | – | 0.05% | 71 |
|
|
2020
Q4 | $221K | Buy |
+1,460
| New | +$221K | 0.06% | 69 |
|
|
2020
Q2 | – | Sell |
-1,940
| Closed | -$209K | – | 70 |
|
|
2020
Q1 | $209K | Hold |
1,940
| – | – | 0.08% | 68 |
|
|
2019
Q4 | $234K | Buy |
+1,940
| New | +$234K | 0.06% | 76 |
|
|
2019
Q3 | – | Sell |
-1,940
| Closed | -$212K | – | 84 |
|
|
2019
Q2 | $212K | Buy |
1,940
+90
| +5% | +$9.84K | 0.06% | 74 |
|
|
2019
Q1 | $207K | Buy |
+1,850
| New | +$207K | 0.06% | 80 |
|
|
2018
Q4 | – | Sell |
-1,995
| Closed | -$243K | – | 79 |
|
|
2018
Q3 | $243K | Hold |
1,995
| – | – | 0.06% | 75 |
|
|
2018
Q2 | $219K | Hold |
1,995
| – | – | 0.06% | 76 |
|
|
2018
Q1 | $213K | Sell |
1,995
-125
| -6% | -$13.3K | 0.06% | 88 |
|
|
2017
Q4 | $226K | Buy |
2,120
+5
| +0.2% | +$533 | 0.06% | 88 |
|
|
2017
Q3 | $235K | Sell |
2,115
-195
| -8% | -$21.7K | 0.07% | 80 |
|
|
2017
Q2 | $239K | Buy |
2,310
+45
| +2% | +$4.66K | 0.07% | 81 |
|
|
2017
Q1 | $221K | Buy |
+2,265
| New | +$221K | 0.07% | 88 |
|